Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Generex Biotechnology Corp GNBT
(Total Views: 279)
Posted On: 07/10/2019 8:17:41 PM
Post# of 36566
Posted By: rjs9787
“leveraging Generex’s legacy assets which have applied over $400 million dollars in developmental activities over the years, providing Generex with net operating loss (“NOL”) carryforwards from both United States and Canadian sources. Generex has NOL carryforwards totaling $241.5 million in the United States expiring in 2019 through 2038; and $35.6 in Canada expiring in 2024 through 2039. On December 1, 2018, the loss carryforwards accumulated from sources in the United States are subject to an annual limitation of approximately $36.9 million annually on a go forewarned basis. Under the Tax Cuts and Jobs Acts (the “Act”), additional NOL carryovers of approximately $4.6 million can be utilized entirely subject to the 80 percent of a taxpayer’s pre-NOL deduction taxable income.“

I think that’s all very positive and important. Especially as Generex begins to grow revenue these tax write offs are huge.













(3)
(0)









  • New Post - Investors HangoutNew Post

  • Public Reply - Investors HangoutPublic Reply

  • Private Reply - Investors HangoutPrivate Reply

  • Board - Investors HangoutBoard

  • More - Investors HangoutMore

  • Keep Post - Investors HangoutKeep Post
  • Report Post - Investors HangoutReport Post
  • Home - Investors HangoutHome
  • Mailbox - Investors HangoutMailbox
  • Boards - Investors HangoutBoards
  • Favorites - Investors HangoutFavorites
  • Whats Hot! - Investors HangoutWhats Hot!
  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site